An international consortium of industry-leading companies
The TVG regional affiliate program is an international consortium of regional trade and business development organizations focused on promoting the growth of the life science and biotechnology industries worldwide. Regional affiliates include important industry associations and government institutions in every major biotech hub, across thirteen countries. Through our regional affiliates we can help you connect with companies, potential business partners, government representatives, and supporting regional networks wherever the life science industry is expanding.
Biominas Brasil
Brazilhttp://www.biominas.org.br
BIOMINAS Brasil is a non profit private institution, created in 1990, devoted to the development of the biotech sector in Brazil. BIOMINAS acts on the generation and development of new businesses and on the support of the biotech sector. These actions have contributed to the creation, in the last years, of more than 30 companies in Minas Gerais and to the recognition of the state as the most important biotechnology cluster in South American.
AusBiotech 2010 national conference - "Creating Global Solutions"
October 19 - 22, 2010Melbourne Convention & Exhibition Venue, Melbourne, Victoria, Australia
http://www.ausbiotech2010.com.au/
AusBiotech 2010, with its key theme 'Creating Global Solutions', will focus on the solutions that biotechnology is developing to deliver a brighter future. Whether it is in new therapies, diagnostics, medical devices, agricultural, industrial or climate change, biotechnology is at the heart of finding better options and answers to issues that we share around the globe. From the research laboratory, through the process of development and commercialisation, to the consumer, it's all about creating solutions.
This event will bring together representatives and professionals from across the biotechnology industry and the globe to produce a world-class event. A comprehensive and integrated conference program will encompass an extensive BioIndustry Exhibition and the increasingly popular Business Matching Program to demonstrate how AusBiotech has earned its reputation as a host for this flagship industry event.
The AusBiotech national conference attracts senior people from across the sector as well as investors and business development professionals. The attendance of prominent biotech individuals, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.
Based on past attendee survey results, the top reasons to attend the AusBiotech national conference are focused on networking and expanding business contacts. Our event delivers many vital opportunities, formal and informal, to meet, greet and discuss business with colleagues from Australia, the Asia-Pacific region and around the globe. Face-to-face interaction is vital when it comes to having productive discussions and making deals.
November 12, 2009
AusBiotech 2009 Confirms Biotech Sector in Recovery
The AusBiotech 2009 conference has confirmed the Australian biotechnology sector is on the rise again, having survived the economic downturn and emerging stronger than before. 1423 delegates from 30 countries around the world gathered in Melbourne from 27-30 October for the industrys premier biotechnology conference in the Asia Pacific region. The event was a resounding success and a fantastic showcase of local research and development, highlighting the investment potential of both the early and late stage work currently taking place in Australia, said Dr Anna Lavelle, CEO AusBiotech.
The conference provided invaluable opportunities for relationships and partnerships to be forged amongst representatives from Australian biotechs and international and local investors and pharmaceutical companies. More than 3680 meetings were requested throughout the duration of the conference, with 2159 confirmed through the Business Matching Program.
Following the success of last years conference, AusBiotech 2009 was yet another great event. Importantly it demonstrated the recovery of the biotech industry out of the economic downturn and pointed to the emergence of a stronger sector than ever before as a result of local R&D successes close to market and increased investment in Australian companies, said Dr Lavelle.
